P Michael Grossman, Devraj Sukul, Shelly C Lall, Pedro A Villablanca, Francis Shannon, Milan Seth, Stanley J Chetcuti, Himanshu J Patel, G Michael Deeb
BACKGROUND: The 30-day rate of stroke after transcatheter aortic valve replacement (TAVR) has been suggested as a hospital quality metric. Thirty-day stroke rates for nonsurgical, high, and moderate-risk TAVR trials were 3.4% to 6.1%, whereas those in the national Transcatheter Valve Therapy (TVT) Registry for the same patient population were much lower. Hospital comprehensive stroke center (CSC) is the highest designation for integrated acute stroke recognition, management, and care...
January 23, 2023: JACC. Cardiovascular Interventions